Aurinia Pharmaceuticals Inc (AUP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 318 | 463 | 420 | 173 | 235 |
| Cost of Goods | N/A | N/A | 1 | 4 | 12 |
| Gross Profit | N/A | N/A | 419 | 169 | 223 |
| Operating Expenses | 76,568 | 56,621 | 47,482 | 22,983 | 23,803 |
| Operating Income | -76,250 | -56,158 | -47,063 | -22,814 | -23,580 |
| Interest Expense | 39 | N/A | N/A | N/A | N/A |
| Other Income | -47,413 | -7,889 | -23,729 | -481 | 4,973 |
| Pre-tax Income | -123,702 | -64,047 | -70,792 | -23,295 | -18,607 |
| Income Tax | 144 | 73 | N/A | N/A | N/A |
| Net Income Continuous | -123,846 | -64,120 | -70,792 | -23,295 | -18,607 |
| Net Income | $-123,846 | $-64,120 | $-70,792 | $-23,295 | $-18,607 |
| EPS Basic Total Ops | -1.33 | -0.76 | -0.92 | -0.66 | -0.58 |
| EPS Basic Continuous Ops | -1.33 | -0.76 | -0.92 | -0.66 | -0.58 |
| EPS Diluted Total Ops | -1.33 | -0.76 | -0.92 | -0.66 | -0.58 |
| EPS Diluted Continuous Ops | -1.33 | -0.76 | -0.92 | -0.66 | -0.58 |
| EBITDA(a) | $-122,115 | $-54,593 | $-45,607 | $-21,335 | $-22,022 |